Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group
| dc.contributor.author | Chotiyarnwong P. | |
| dc.contributor.author | McCloskey E.V. | |
| dc.contributor.author | Harvey N.C. | |
| dc.contributor.author | Lorentzon M. | |
| dc.contributor.author | Prieto-Alhambra D. | |
| dc.contributor.author | Abrahamsen B. | |
| dc.contributor.author | Adachi J.D. | |
| dc.contributor.author | Borgström F. | |
| dc.contributor.author | Bruyere O. | |
| dc.contributor.author | Carey J.J. | |
| dc.contributor.author | Clark P. | |
| dc.contributor.author | Cooper C. | |
| dc.contributor.author | Curtis E.M. | |
| dc.contributor.author | Dennison E. | |
| dc.contributor.author | Diaz-Curiel M. | |
| dc.contributor.author | Dimai H.P. | |
| dc.contributor.author | Grigorie D. | |
| dc.contributor.author | Hiligsmann M. | |
| dc.contributor.author | Khashayar P. | |
| dc.contributor.author | Lewiecki E.M. | |
| dc.contributor.author | Lips P. | |
| dc.contributor.author | Lorenc R.S. | |
| dc.contributor.author | Ortolani S. | |
| dc.contributor.author | Papaioannou A. | |
| dc.contributor.author | Silverman S. | |
| dc.contributor.author | Sosa M. | |
| dc.contributor.author | Szulc P. | |
| dc.contributor.author | Ward K.A. | |
| dc.contributor.author | Yoshimura N. | |
| dc.contributor.author | Kanis J.A. | |
| dc.contributor.other | Mahidol University | |
| dc.date.accessioned | 2023-06-18T17:39:06Z | |
| dc.date.available | 2023-06-18T17:39:06Z | |
| dc.date.issued | 2022-12-01 | |
| dc.description.abstract | Summary: The IOF Epidemiology and Quality of Life Working Group has reviewed the potential role of population screening for high hip fracture risk against well-established criteria. The report concludes that such an approach should strongly be considered in many health care systems to reduce the burden of hip fractures. Introduction: The burden of long-term osteoporosis management falls on primary care in most healthcare systems. However, a wide and stable treatment gap exists in many such settings; most of which appears to be secondary to a lack of awareness of fracture risk. Screening is a public health measure for the purpose of identifying individuals who are likely to benefit from further investigations and/or treatment to reduce the risk of a disease or its complications. The purpose of this report was to review the evidence for a potential screening programme to identify postmenopausal women at increased risk of hip fracture. Methods: The approach took well-established criteria for the development of a screening program, adapted by the UK National Screening Committee, and sought the opinion of 20 members of the International Osteoporosis Foundation’s Working Group on Epidemiology and Quality of Life as to whether each criterion was met (yes, partial or no). For each criterion, the evidence base was then reviewed and summarized. Results and Conclusion: The report concludes that evidence supports the proposal that screening for high fracture risk in primary care should strongly be considered for incorporation into many health care systems to reduce the burden of fractures, particularly hip fractures. The key remaining hurdles to overcome are engagement with primary care healthcare professionals, and the implementation of systems that facilitate and maintain the screening program. | |
| dc.identifier.citation | Archives of Osteoporosis Vol.17 No.1 (2022) | |
| dc.identifier.doi | 10.1007/s11657-022-01117-6 | |
| dc.identifier.eissn | 18623514 | |
| dc.identifier.issn | 18623522 | |
| dc.identifier.pmid | 35763133 | |
| dc.identifier.scopus | 2-s2.0-85132973607 | |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/85292 | |
| dc.rights.holder | SCOPUS | |
| dc.subject | Medicine | |
| dc.title | Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group | |
| dc.type | Article | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85132973607&origin=inward | |
| oaire.citation.issue | 1 | |
| oaire.citation.title | Archives of Osteoporosis | |
| oaire.citation.volume | 17 | |
| oairecerif.author.affiliation | Siriraj Hospital | |
| oairecerif.author.affiliation | Michael G. DeGroote School of Medicine | |
| oairecerif.author.affiliation | Université de Lyon | |
| oairecerif.author.affiliation | Ghent university, Center for Microsystems Technology | |
| oairecerif.author.affiliation | University Hospital Galway | |
| oairecerif.author.affiliation | Universitatea de Medicina si Farmacie Carol Davila din Bucuresti | |
| oairecerif.author.affiliation | Universidad Nacional Autónoma de México | |
| oairecerif.author.affiliation | McMaster University | |
| oairecerif.author.affiliation | University of Oxford | |
| oairecerif.author.affiliation | The University of Tokyo | |
| oairecerif.author.affiliation | University of Southampton | |
| oairecerif.author.affiliation | Hospital Universitario Fundación Jiménez Díaz | |
| oairecerif.author.affiliation | Syddansk Universitet | |
| oairecerif.author.affiliation | Universiteit Maastricht | |
| oairecerif.author.affiliation | Göteborgs Universitet | |
| oairecerif.author.affiliation | Cedars-Sinai Medical Center | |
| oairecerif.author.affiliation | Karolinska Institutet | |
| oairecerif.author.affiliation | C.I. Parhon Institute of Endocrinology | |
| oairecerif.author.affiliation | Australian Catholic University | |
| oairecerif.author.affiliation | Universidad de Las Palmas de Gran Canaria | |
| oairecerif.author.affiliation | The Sheffield Medical School | |
| oairecerif.author.affiliation | Vrije Universiteit Amsterdam | |
| oairecerif.author.affiliation | University of Galway | |
| oairecerif.author.affiliation | IRCCS Istituto Auxologico Italiano | |
| oairecerif.author.affiliation | Medizinische Universität Graz | |
| oairecerif.author.affiliation | New Mexico Clinical Research and Osteoporosis Center | |
| oairecerif.author.affiliation | Holbæk Sygehus | |
| oairecerif.author.affiliation | The University of Sheffield | |
| oairecerif.author.affiliation | Instituto de Salud Carlos III | |
| oairecerif.author.affiliation | Université de Liège | |
| oairecerif.author.affiliation | GERAS Centre for Aging Research | |
| oairecerif.author.affiliation | SOMED | |
| oairecerif.author.affiliation | Quantify Research |
